NEWS IN BRIEF
Asia-Pacific CRO Novotech signs MOU with Taiwanese hospital
Novotech has signed a Memorandum of Understanding (MOU) with the China Medical University Hospital (CMUH) in Taiwan.
The Australia-headquartered contract research organization (CRO) Novotech have five MOUs with major health providers.
Per its agreement with the CMUH, the hospital will provide Novotech’s team with “professional and medical clinical trial advice,” including feasibility, principal investigator selection, and patient recruitment support.
Conversely, Novotech will promote CMUH’s clinical research capabilities, specifically its Phase I unit.
The CMUH has 2,054 beds and a dedicated Clinical Trials Center (CTC), which joined the "International Clinical Trials Center Network" (ICN) in 2016.
The ICN includes Zurich University, Harvard University, Cambridge University, and the University of Hong Kong.
